The E3-Ligase TRIM Family of Proteins Regulates Signaling Pathways Triggered by Innate Immune Pattern-Recognition Receptors

Immunity

Volumn 38, Issue 2, 2013, Pages 384-398

  Versteeg, Gijs A ^a   Rajsbaum, Ricardo ^a   Sánchez Aparicio, Maria Teresa ^a   Maestre, Ana M ^a   Valdiviezo, Julio ^a   Shi, Mude ^b   Inn, Kyung Soo ^b,c   Fernandez Sesma, Ana ^a   Jung, Jae ^b   García Sastre, Adolfo ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c Kyung Hee University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PATTERN RECOGNITION RECEPTOR; PROTEASOME; TRANSCRIPTION FACTOR; TRIPARTITE MOTIF PROTEIN 5; UBIQUITIN PROTEIN LIGASE E3;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMBRYO; HUMAN; HUMAN CELL; INNATE IMMUNITY; LUNG ALVEOLUS CELL; MOLECULAR CLONING; PATTERN RECOGNITION; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROCESSING; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VIRUS INFECTION;

ALTERNATIVE SPLICING; CARRIER PROTEINS; CELL LINE; CLONING, MOLECULAR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; LEUKOCYTES, MONONUCLEAR; PROTEIN ISOFORMS; RECEPTORS, PATTERN RECOGNITION; RHABDOVIRIDAE INFECTIONS; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; VESICULOVIRUS; ZINC FINGERS;

EID: 84874256730     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2012.11.013     Document Type: Article

References (32)

1. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
2. Arimoto K., Funami K., Saeki Y., Tanaka K., Okawa K., Takeuchi O., Akira S., Murakami Y., Shimotohno K. Polyubiquitin conjugation to NEMO by triparite motif protein 23 (TRIM23) is critical in antiviral defense. Proc. Natl. Acad. Sci. USA 2010, 107:15856-15861.
3. Baum A., Sachidanandam R., García-Sastre A. Preference of RIG-I for short viral RNA molecules in infected cells revealed by next-generation sequencing. Proc. Natl. Acad. Sci. USA 2010, 107:16303-16308.
4. Berger G., Durand S., Goujon C., Nguyen X.N., Cordeil S., Darlix J.L., Cimarelli A. A simple, versatile and efficient method to genetically modify human monocyte-derived dendritic cells with HIV-1-derived lentiviral vectors. Nat. Protoc. 2011, 6:806-816.
5. Carthagena L., Bergamaschi A., Luna J.M., David A., Uchil P.D., Margottin-Goguet F., Mothes W., Hazan U., Transy C., Pancino G., Nisole S. Human TRIM gene expression in response to interferons. PLoS ONE 2009, 4:e4894.
6. Cuchet D., Sykes A., Nicolas A., Orr A., Murray J., Sirma H., Heeren J., Bartelt A., Everett R.D. PML isoforms I and II participate in PML-dependent restriction of HSV-1 replication. J. Cell Sci. 2011, 124:280-291.
7. Fang S., Lorick K.L., Jensen J.P., Weissman A.M. RING finger ubiquitin protein ligases: implications for tumorigenesis, metastasis and for molecular targets in cancer. Semin. Cancer Biol. 2003, 13:5-14.
8. Fernandez-Sesma A., Marukian S., Ebersole B.J., Kaminski D., Park M.S., Yuen T., Sealfon S.C., García-Sastre A., Moran T.M. Influenza virus evades innate and adaptive immunity via the NS1 protein. J. Virol. 2006, 80:6295-6304.
9. Gack M.U., Shin Y.C., Joo C.H., Urano T., Liang C., Sun L., Takeuchi O., Akira S., Chen Z., Inoue S., Jung J.U. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
10. Gack M.U., Kirchhofer A., Shin Y.C., Inn K.S., Liang C., Cui S., Myong S., Ha T., Hopfner K.P., Jung J.U. Roles of RIG-I N-terminal tandem CARD and splice variant in TRIM25-mediated antiviral signal transduction. Proc. Natl. Acad. Sci. USA 2008, 105:16743-16748.
11. Haye K., Burmakina S., Moran T., García-Sastre A., Fernandez-Sesma A. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J. Virol. 2009, 83:6849-6862.
12. Kahn A.B., Ryan M.C., Liu H., Zeeberg B.R., Jamison D.C., Weinstein J.N. SpliceMiner: a high-throughput database implementation of the NCBI Evidence Viewer for microarray splice variant analysis. BMC Bioinformatics 2007, 8:75.
13. Kawai T., Akira S. Regulation of innate immune signalling pathways by the tripartite motif (TRIM) family proteins. EMBO Mol Med 2011, 3:513-527.
14. Lallemand-Breitenbach V., Zhu J., Puvion F., Koken M., Honoré N., Doubeikovsky A., Duprez E., Pandolfi P.P., Puvion E., Freemont P., de Thé H. Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation. J. Exp. Med. 2001, 193:1361-1371.
15. McNab F.W., Rajsbaum R., Stoye J.P., O'Garra A. Tripartite-motif proteins and innate immune regulation. Curr. Opin. Immunol. 2011, 23:46-56.
16. Napolitano L.M., Jaffray E.G., Hay R.T., Meroni G. Functional interactions between ubiquitin E2 enzymes and TRIM proteins. Biochem. J. 2011, 434:309-319.
17. Ozato K., Shin D.M., Chang T.H., Morse H.C. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 2008, 8:849-860.
18. Pertel T., Hausmann S., Morger D., Züger S., Guerra J., Lascano J., Reinhard C., Santoni F.A., Uchil P.D., Chatel L., et al. TRIM5 is an innate immune sensor for the retrovirus capsid lattice. Nature 2011, 472:361-365.
19. Rajsbaum R., Stoye J.P., O'Garra A. Type I interferon-dependent and -independent expression of tripartite motif proteins in immune cells. Eur. J. Immunol. 2008, 38:619-630.
20. Rhodes D.A., de Bono B., Trowsdale J. Relationship between SPRY and B30.2 protein domains. Evolution of a component of immune defence?. Immunology 2005, 116:411-417.
21. Short K.M., Cox T.C. Subclassification of the RBCC/TRIM superfamily reveals a novel motif necessary for microtubule binding. J. Biol. Chem. 2006, 281:8970-8980.
22. Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell 2010, 140:805-820.
23. Toniato E., Chen X.P., Losman J., Flati V., Donahue L., Rothman P. TRIM8/GERP RING finger protein interacts with SOCS-1. J. Biol. Chem. 2002, 277:37315-37322.
24. Tsuchida T., Zou J., Saitoh T., Kumar H., Abe T., Matsuura Y., Kawai T., Akira S. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 2010, 33:765-776.
25. Uchil P.D., Hinz A., Siegel S., Coenen-Stass A., Pertel T., Luban J., Mothes W. TRIM protein mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J. Virol. 2012, 87:257-272.
26. Xue Q., Zhou Z., Lei X., Liu X., He B., Wang J., Hung T. TRIM38 negatively regulates TLR3-MEdiated IFN-β signaling by targeting TRIF for degradation. PLoS ONE 2012, 7:e46825.
27. Yang K., Shi H.X., Liu X.Y., Shan Y.F., Wei B., Chen S., Wang C. TRIM21 is essential to sustain IFN regulatory factor 3 activation during antiviral response. J. Immunol. 2009, 182:3782-3792.
28. Yoneyama M., Fujita T. Recognition of viral nucleic acids in innate immunity. Rev. Med. Virol. 2010, 20:4-22.
29. Yoneyama M., Suhara W., Fukuhara Y., Fukuda M., Nishida E., Fujita T. Direct triggering of the type I interferon system by virus infection: activation of a transcription factor complex containing IRF-3 and CBP/p300. EMBO J. 1998, 17:1087-1095.
30. Yoshimi R., Chang T.H., Wang H., Atsumi T., Morse H.C., Ozato K. Gene disruption study reveals a nonredundant role for TRIM21/Ro52 in NF-kappaB-dependent cytokine expression in fibroblasts. J. Immunol. 2009, 182:7527-7538.
31. Zhao W., Wang L., Zhang M., Wang P., Yuan C., Qi J., Meng H., Gao C. Tripartite motif-containing protein 38 negatively regulates TLR3/4- and RIG-I-mediated IFN-β production and antiviral response by targeting NAP1. J. Immunol. 2012, 188:5311-5318.
32. Zhao W., Wang L., Zhang M., Yuan C., Gao C. E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages. J. Immunol. 2012, 188:2567-2574.